Developers of gene therapies to treat knee osteoarthritis are taking the familiar intra-articular route to deliver proteins and molecules directly to the site of the disease.

AI marks a fundamental shift from information access to reasoning access enabling non-specialists to engage competently ...

As of March 2026, TestoPrime is available in over 130 countries and holds the Clinicians' Choice medical accreditation as ...